Nucleai
Esther Abels is the CEO and founder of SolarisRTC, a position held since March 2023, while also serving as an independent consultant specializing in regulatory, clinical, and quality aspects of Pharma and in vitro diagnostics. With a career spanning over a decade in various leadership roles within the Digital Pathology Association, including Past President and currently serving as a Board Member, Esther has driven significant developments in regulatory standards and practices. Previous experience includes key positions at Visiopharm and PathAI, focusing on regulatory, clinical, and market access strategies aimed at enhancing product development and innovation in personalized medicine. Esther holds a Master’s degree in Biomedical Health Science from Radboud University, completed in 1998.
This person is not in the org chart
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.